The cases that met the definition of the inflammatory condition were reported to the CDC from 40 state health departments, the District of Columbia and New York City. The illnesses began between March 2 and July 18. The young people affected by the condition ranged in age from 2 weeks to 20 years, with a median age of 8 years. Of the 565 who underwent COVID-19 testing, all tested positive.
Nearly half (40.5 percent) were Hispanic or Latino, and a third (33.1 percent) were Black. A little over 13 percent were white. Obesity was the most commonly reported underlying condition, occurring in 30.5 percent of Hispanic, 27.5 percent of Black, and 6.6 percent of white MIS-C patients.
The report shows the most common signs and symptoms reported during illness were abdominal pain (61.9 percent), vomiting (61.8 percent), skin rash (55.3 percent) and diarrhea (53.2 percent). Slightly more than 40 percent experienced cardiac dysfunction, and 35.4 percent experienced shock. Most patients (63.9 percent) were admitted to an intensive care unit, and 1.8 percent died.
More articles on public health:
California public health director abruptly resigns
Positive COVID-19 tests, ED visits drop nationwide: 4 CDC updates
35% of Americans wouldn’t get free, FDA-approved COVID-19 vaccine
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
